Edition:
United States

IRIDEX Corp (IRIX.OQ)

IRIX.OQ on NASDAQ Stock Exchange Global Market

8.10USD
17 Aug 2018
Change (% chg)

-- (--)
Prev Close
$8.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
4,158
52-wk High
$10.35
52-wk Low
$4.78

Chart for

About

IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumenta... (more)

Overall

Beta: 1.52
Market Cap(Mil.): $94.48
Shares Outstanding(Mil.): 11.66
Dividend: --
Yield (%): --

Financials

  IRIX.OQ Industry Sector
P/E (TTM): -- 44.74 30.45
EPS (TTM): -1.30 -- --
ROI: -47.94 7.91 12.63
ROE: -48.80 11.65 14.82

BRIEF-Iridex Corp Q1 Revenue $9.5 Million

* REITERATED ITS GUIDANCE FOR 2018 OF G6 PROBE SHIPMENTS OF 40,000 TO 45,000,

May 03 2018

BRIEF-Iridex Announces Availability Of G-Probe Illuminate Device In Europe

* IRIDEX CORP - AVAILABILITY OF G-PROBE ILLUMINATE DEVICE IN EUROPE Source text for Eikon: Further company coverage:

Mar 20 2018

BRIEF-Iridex Qtrly Loss Per Share $0.44

* IRIDEX ANNOUNCES 2017 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS

Mar 08 2018

BRIEF-Iridex Issues Voluntary Recall Of Trufocus Lio Premiere Laser Indirect Ophthalmoscope

* IRIDEX ISSUES VOLUNTARY RECALL OF TRUFOCUS LIO PREMIERE™ LASER INDIRECT OPHTHALMOSCOPE

Feb 23 2018

Earnings vs. Estimates